Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Monk

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Drugs|September 1, 1988
Sufentanil. A review of its pharmacological properties and therapeutic useJ P Monk, R Beresford, A Ward
Drugs|April 1, 1987
Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic useJ P Monk, D M Campoli-Richards
Drugs|August 1, 1988
Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer diseaseA J Wagstaff, P Benfield, J P Monk
Drugs|October 1, 1987
Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacyD M Campoli-Richards, T E Lackner, J P Monk
Drugs|October 1, 1988
Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertensionE Saltiel, A G Ellrodt, J P Monk, et al.
Drugs|April 1, 1988
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic useD M Campoli-Richards, J P Monk, A Price, et al.
Cancer Treatment and Research Communications|July 13, 2019
Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421P N Lara, M Plets, C Tangen, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Drugs|September 1, 1988
Sufentanil. A review of its pharmacological properties and therapeutic useJ P Monk, R Beresford, A Ward
Drugs|April 1, 1987
Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic useJ P Monk, D M Campoli-Richards
Drugs|August 1, 1988
Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer diseaseA J Wagstaff, P Benfield, J P Monk
Drugs|October 1, 1987
Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacyD M Campoli-Richards, T E Lackner, J P Monk
Drugs|October 1, 1988
Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertensionE Saltiel, A G Ellrodt, J P Monk, et al.
Drugs|April 1, 1988
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic useD M Campoli-Richards, J P Monk, A Price, et al.
Cancer Treatment and Research Communications|July 13, 2019
Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421P N Lara, M Plets, C Tangen, et al.
Pageof 2